Posted in ace2 elisa, aflatoxin elisa, Antibodies, Assay Kits, Biology Cells, cDNA, Clia Kits, Culture Cells, Devices, DNA, DNA Templates, dylight 488, Elisa Kits, Enzymes, Equipments, Exosomes, fgf21 elisa, Gels, igf1 elisa, igf2 elisa kit, il3 elisa, Isotypes, mag antibody, Medium & Serums, NATtrol, Panel, Particles, PCR, Pcr Kits, Peptides, rat elisa kits, Reagents, Recombinant Proteins, research antibody, Ria Kits, RNA, Test Kits, Vector & Virus, Western Blot

Identification of low molecular weight degradation merchandise from chitin and chitosan

cd1234567890

Identification of low molecular weight degradation merchandise from chitin and chitosan by electrospray ionization time-of-flight mass spectrometry

The helpful results offered by chitosan oligosaccharides (COS) make them of curiosity in medical analysis.
The monomers that represent COS confer distinct properties, so controlling COS composition throughout their manufacturing is important.
On this work, we degraded chitin and chitosan polymers and recognized low molecular weight merchandise resembling COS that shaped, utilizing electrospray ionization time-of-flight mass spectrometry.
Our outcomes present that hydrochloric acid, hydrogen peroxide, and nitrous acid generate distinct merchandise from chitin and chitosan.
Hydrochloric acid degrades chitin and chitosan to provide glucosamine (GlcN) monomers and oligomers. Hydrogen peroxide degrades chitosan to provide GlcN and N-acetyl-d-glucosamine (GlcNAc) monomers and oligomers, and nitrous acid degrades chitosan to provide 2,5-anhydro- d-mannose.
Our research present that COS composition is dictated by each the degradation protocol and the beginning polymer. Moreover, our outcomes allow number of degradation protocols primarily based on their capacity to degrade chitin and chitosan and facilitate the manufacturing of COS with desired compositions.
Key phrases: Chitin; Chitosan; Mass spectrometry; Polysaccharide degradation.
cd1234567890
cd1234567890

H3N2 Influenza-A Virus Brisbane 10/07
rAP-5410 Inquiry Ask for price

Influenza A Virus H3N2 Brisbane 10 / 07 Protein
20-abx260509
  • Ask for price
  • Ask for price
  • Ask for price
  • 10 ug
  • 1 mg
  • 50 ug

Influenza A Virus H3N2 Brisbane 10 / 07 Protein
abx260509-10g 10 µg
EUR 325

Influenza A Virus H3N2 Brisbane 10 / 07 Protein
abx260509-2g 2 µg
EUR 225

Influenza A Strain A/Brisbane/10/07 (H3N2) Antigen
11-567 0.1 mg
EUR 632.4
Description: Influenza A (A/Brisbane/10/07), Influenza A Virus, Strain A/Brisbane/10/07 (H3N2)

Influenza A Strain A/Brisbane/10/07 (H3N2) Protein
GWB-T00035 1mg Ask for price

Influenza A Strain A/Brisbane/10/07 (H3N2) Antigen Liquid
IFLUABN1007H3N2ALR100UG each
EUR 738
Description: Influenza A Strain A/Brisbane/10/07 (H3N2) Antigen Liquid

H3N2 Influenza A- Virus Brisbane 10/2007 Recombinant
rAP-5428 Inquiry Ask for price

Influenza A H3N2 (A/Brisbane/10/2007) HA protein, His Tag
E40VAG023 20ug
EUR 495

H1N1 Influenza A- Virus Brisbane 59/2007 Recombinant
rAP-5423 Inquiry Ask for price

Influenza A H1N1 (A/Brisbane/59/2007) HA protein, His Tag
E40VAG011 20ug
EUR 495

Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin Antibody Pair Set
ABPR-ZB267 5 plates, 15 plates Ask for price
Description: Quantitative determination of Influenza Hemagglutinin

Influenza A H3N2 (A/Brisbane/10/2007) HA Protein (HA1 Subunit), His Tag
E40VAG022 20ug
EUR 495

Influenza A Hemagglutinin H1 (A/Brisbane/59/2007)(H1N1) Peptide
11-563 0.05 mg
EUR 632.4
Description: Influenza A Hemagglutinin H1 (A/Brisbane/59/2007)(H1N1) Peptide

Influenza A Hemagglutinin H1 (A/Brisbane/59/2007)(H1N1) Peptide
11-564 0.05 mg
EUR 632.4
Description: Influenza A Hemagglutinin H1 (A/Brisbane/59/2007)(H1N1) Peptide

Influenza B- Virus Brisbane 60/2008 Recombinant
rAP-5434 Inquiry Ask for price

Influenza B (B/Brisbane/60/2008) HA protein, His Tag
E40VAG161 20ug
EUR 495

Influenza B (B/Brisbane/60/2008) HA protein, His Tag
E40VAG163 20ug
EUR 495

Influenza A H1N1 (A/Brisbane/59/2007) HA Protein (HA1 Subunit), His Tag
E40VAG010 20ug
EUR 495

Influenza B (B/Brisbane/60/2008) HA Protein (HA1 Subunit), His Tag
E40VAG162 20ug
EUR 495

Influenza B (B/Brisbane/3/2007) HA Protein (HA1 Subunit), His Tag
E40VAG283 20ug
EUR 495

Rabbit Anti-IBV (Influenza B/Brisbane/60/2008) HA2 Polyclonal Antibody
CABT-CS796 100 μg
EUR 520
Description: Rabbit

Influenza A H1N1pdm (Brisbane/2/18) Culture Fluid (Heat Inactivated) (1 mL)
0810585CFHI 1 mL
EUR 422

Recombinant Influenza H3N2 Brisbane Protein, Untagged, Insect-10ug
QP12081-10ug 10ug
EUR 186

Recombinant Influenza H3N2 Brisbane Protein, Untagged, Insect-1mg
QP12081-1mg 1mg
EUR 2470.8

Recombinant Influenza H3N2 Brisbane Protein, Untagged, Insect-50ug
QP12081-50ug 50ug
EUR 241.2

Recombinant (HEK) purified Influenza A nucleoprotein (H1N1-NP/1-486aa) protein (A/Brisbane/59/2007, >95%, His-tag)
H1NP26-R-25 25 ug
EUR 416.4

Recombinant (HEK) purified Influenza B HA1 protein (B/Brisbane/60/2008)(aa.16-363, >95%, his-tag)
HA1B012-R-10 10 ug
EUR 343.2

Recombinant (HEK) purified Influenza B HA1 protein (B/Brisbane/60/2008)(aa.16-363, >95%, his-tag)
HA1B012-R-100 100 ug
EUR 927.6

Recombinant (HEK) purified Influenza B HA protein (B/Brisbane/60/2008, ?TM, 16-548aa, >95%, his-tag)
HA1B013-R-10 10 ug
EUR 343.2

Recombinant (HEK) purified Influenza B HA protein (B/Brisbane/60/2008, ?TM, 16-548aa, >95%, his-tag)
HA1B013-R-100 100 ug
EUR 927.6

Influenza A [A/California/07/2009 (H1N1pdm)] Viral Lysate
NAT41634-100 0.1
EUR 512.85
Description: Influenza A H1N1 Pandemic 2009 (H1N1pdm) virus is propagated in the MDCK cell line. Virus is purified using sucrose density gradient ultracentrifugation, disrupted in the presence of 0.5% Triton X-100 non-ionic detergent/0.6 M KCl, and heat inactivated.

Influenza A [A/California/07/2009 (H1N1pdm)] Viral Lysate
NAT41634-500 0.5
EUR 2181.53
Description: Influenza A H1N1 Pandemic 2009 (H1N1pdm) virus is propagated in the MDCK cell line. Virus is purified using sucrose density gradient ultracentrifugation, disrupted in the presence of 0.5% Triton X-100 non-ionic detergent/0.6 M KCl, and heat inactivated.

Brisbane 1007
iha-024 10µg
EUR 60
Description: Influenza A Virus H3N2 Brisbane 1007

IAV H3N2 (aa 18-530) (A/Brisbane/10/2007) [His]
DAG1693 50 ug
EUR 2017.2

IAV H3N2 nucleoprotein (A/Brisbane/10/2007) [His]
DAG2329 100 µg
EUR 868.8

Influenza A [A/Hong Kong/8/1968 (H3N2)] Viral Lysate
NAT41641-100 0.1
EUR 523.06
Description: Influenza virus is propagated in the MDCK cell line. Virus is purified using sucrose density gradient ultracentrifugation, disrupted in the presence of 0.5% Triton X-100 non-ionic detergent/0.6 M KCl, and heat inactivated.

Influenza A [A/Hong Kong/8/1968 (H3N2)] Viral Lysate
NAT41641-500 0.5
EUR 2181.53
Description: Influenza virus is propagated in the MDCK cell line. Virus is purified using sucrose density gradient ultracentrifugation, disrupted in the presence of 0.5% Triton X-100 non-ionic detergent/0.6 M KCl, and heat inactivated.

IAV H3N2 non-structural 1 (A/Brisbane/10/2007 ) [His]
DAG2335 100 µg
EUR 868.8

Influenza A [A/New Caledonia/20/1999 (H1N1)] Viral Lysate
NAT41629-100 0.1
EUR 512.85
Description: Influenza virus is propagated in the MDCK cell line. Virus is purified using sucrose density gradient ultracentrifugation, disrupted in the presence of 0.5% Triton X-100 non-ionic detergent/0.6 M KCl, and heat inactivated.

Influenza A [A/New Caledonia/20/1999 (H1N1)] Viral Lysate
NAT41629-500 0.5
EUR 2181.53
Description: Influenza virus is propagated in the MDCK cell line. Virus is purified using sucrose density gradient ultracentrifugation, disrupted in the presence of 0.5% Triton X-100 non-ionic detergent/0.6 M KCl, and heat inactivated.

Mouse Monoclonal Anti-Influenza A HA (H3N2, 1-531aa/HA1+HA2) (A/Brisbane/10/2007) protein IgG
H3N21-M 100 ul
EUR 578.4

Rabbit Anti-Influenza A HA (H3N2, 1-531aa/HA1+HA2) (A/Brisbane/10/2007) protein IgG, aff pure
H3N23-A 100 ul
EUR 534

Recombinant IAV H3N2 (A/Brisbane/10/2007) Hemagglutinin [His]
DAG-H10412 100 µg
EUR 860
Description: Recombinant

IAV H3N2 Hemagglutinin (aa 17-530) (A/Brisbane/10/2007) [His]
DAG2224 100 µg
EUR 1095.6

IAV H1N1 nucleoprotein (aa 1-486) (A/Brisbane/10/2007) [His]
DAG2328 100 µg
EUR 868.8

IAV H1N1 (aa 18-530) (A/Brisbane/59/2007) [His]
DAG1688 50 ug
EUR 2017.2

IAV H3N2 Hemagglutinin 1 (aa 17-345) (A/Brisbane/10/2007) [His]
DAG2282 100 µg
EUR 1095.6

Rabbit Anti-IAV H3N2 (A/Brisbane/10/2007) M2 Polyclonal Antibody
CABT-CS799 100 μg
EUR 520
Description: Rabbit

IAV H1N1 Hemagglutin (aa 51-301) (A/Brisbane/59/2007) [His]
DAG2202 100 µg
EUR 1095.6

IAV H1N1 Hemagglutin (aa 18-530) (A/Brisbane/59/2007) [His]
DAG2220 100 µg
EUR 1095.6

Influenza A H3 Antibody
abx021977-1mg 1 mg
EUR 1053.6

Influenza A H3 Antibody
abx021978-1mg 1 mg
EUR 1053.6

Influenza A H3 Antibody
abx021977-400l 400 µl Ask for price

Influenza A H3 Antibody
abx021977-80l 80 µl
EUR 975

Influenza A H3 Antibody
abx021978-400l 400 µl Ask for price

Influenza A H3 Antibody
abx021978-80l 80 µl
EUR 975

Influenza B [B/Florida/02/2006] Viral Lysate
NAT41648-100 0.1
EUR 523.06
Description: Influenza virus is propagated in the MDCK cell line. Virus is purified using sucrose density gradient ultracentrifugation, disrupted in the presence of 0.5% Triton X-100 non-ionic detergent/0.6 M KCl, and heat inactivated.

IAV H1N1 Hemagglutin 1 (aa 18-343) (A/Brisbane/59/2007) [His]
DAG1775 50 ug
EUR 2017.2

IAV H1N1 Hemagglutin 1 (aa 18-343) (A/Brisbane/59/2007) [His]
DAG2279 100 µg
EUR 1095.6

IAV H3N2 Hemagglutinin 1 (aa 17-346) (A/Brisbane/299/2011 ) [His]
DAG2246 100 µg
EUR 1095.6

Mouse Anti-IAV H3N2 (A/Brisbane/10/2007) HA Monoclonal Antibody, Clone 75E2
CABT-CS773 100 μg
EUR 645
Description: Mouse

Recombinant IAV H1N1 Protein (aa 18-530) (A/Brisbane/59/2007) [His]
VAng-Lsx0333-inquire inquire Ask for price
Description: IAV H1N1 (aa 18-530) (A/Brisbane/59/2007) [His], recombinant protein from HEK 293 cells.

Influenza B [B/Massachusetts/2/2012] Viral Lysate
NAT41653-100 0.1
EUR 523.06
Description: Influenza virus is propagated in the MDCK cell line. Virus is purified using sucrose density gradient ultracentrifugation, disrupted in the presence of 0.5% Triton X-100 non-ionic detergent/0.6 M KCl, and heat inactivated.

Influenza B [B/Massachusetts/2/2012] Viral Lysate
NAT41653-500 0.5
EUR 2181.53
Description: Influenza virus is propagated in the MDCK cell line. Virus is purified using sucrose density gradient ultracentrifugation, disrupted in the presence of 0.5% Triton X-100 non-ionic detergent/0.6 M KCl, and heat inactivated.

Recombinant IAV H3N2 Hemagglutinin / HA Protein (aa 1-530) [His] (A/Brisbane/10/2007)
VAng-Wyb7007-100g 100 µg
EUR 2089.2
Description: Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin / HA, recombinant protein.

Recombinant IAV H3N2 Hemagglutinin / HA Protein (aa 1-530) [His] (A/Brisbane/10/2007)
VAng-Wyb7007-50g 50 µg
EUR 1260
Description: Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin / HA, recombinant protein.

Influenza A H3 Antigen Antibody
GWB-78ADD7 0.1 mg Ask for price

Recombinant IBV (B/Brisbane/60/2008) HA Protein
DAG-H10446 100 µg
EUR 996
Description: Recombinant

Influenza A virus H3 PCR kit
PCR-H649-48R 50T
EUR 987.6

Influenza A virus H3 PCR kit
PCR-H649-96R 100T
EUR 1335.6

Recombinant IAV H3N2 Hemagglutinin HA1 Subunit Protein (aa 1-345) [His] (A/Brisbane/10/2007)
VAng-Wyb7063-100g 100 µg
EUR 2089.2
Description: Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin HA1 Subunit, recombinant protein.

Recombinant IAV H3N2 Hemagglutinin HA1 Subunit Protein (aa 1-345) [His] (A/Brisbane/10/2007)
VAng-Wyb7063-10g 10 µg
EUR 687.6
Description: Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin HA1 Subunit, recombinant protein.

Recombinant IAV H3N2 Hemagglutinin HA1 Subunit Protein (aa 1-345) [His] (A/Brisbane/10/2007)
VAng-Wyb7063-50g 50 µg
EUR 1260
Description: Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin HA1 Subunit, recombinant protein.

IBV Hemagglutinin (aa 16-548) (B/Brisbane/60/2008) [His]
DAG2215 100 µg
EUR 1095.6

IBV Nucleoprotein (aa 1-560) (B/Brisbane/60/2008) [His]
DAG2319 100 µg
EUR 868.8

OPPA01552-10UG - H3N2 Brisbane Protein
OPPA01552-10UG 10ug
EUR 70

Mouse Anti-IAV H1N1 (A/Brisbane/59/2007) HA Monoclonal Antibody, Clone 9G9
CABT-CS761 100 μg
EUR 645
Description: Mouse

IBV Matrix Proteins 1 (aa 1-252) (B/Brisbane/60/2008) [His]
DAG2304 100 µg
EUR 868.8

IBV Matrix Proteins 1 (aa 1-248) (B/Brisbane/60/2008) [His]
DAG2305 100 µg
EUR 868.8

Influenza A Virus H3 Antigen Antibody
abx415738-01mg 0.1 mg
EUR 861.6

Influenza A Virus H3 Antigen Antibody
abx415738-200l 200 µl
EUR 687.5

Influenza A virus H3 RT PCR kit
RTq-H649-100R 100T
EUR 1573.2

Influenza A virus H3 RT PCR kit
RTq-H649-150R 150T
EUR 2144.4

Influenza A virus H3 RT PCR kit
RTq-H649-50R 50T
EUR 1155.6

Recombinant IAV H1N1 Hemagglutinin / HA Protein (aa 1-528) [His] (A/Brisbane/59/2007)
VAng-Wyb6941-100g 100 µg
EUR 2092.8
Description: Influenza A H1N1 (A/Brisbane/59/2007) Hemagglutinin / HA, recombinant protein.

Recombinant IAV H1N1 Hemagglutinin / HA Protein (aa 1-528) [His] (A/Brisbane/59/2007)
VAng-Wyb6941-10g 10 µg
EUR 687.6
Description: Influenza A H1N1 (A/Brisbane/59/2007) Hemagglutinin / HA, recombinant protein.

Recombinant IAV H1N1 Hemagglutinin / HA Protein (aa 1-528) [His] (A/Brisbane/59/2007)
VAng-Wyb6941-50g 50 µg
EUR 1260
Description: Influenza A H1N1 (A/Brisbane/59/2007) Hemagglutinin / HA, recombinant protein.

Influenza A H1N1 (A/Ohio/07/2009) HA protein, His Tag
E40VAG150 20ug
EUR 495

Influenza B Virus Florida 07/04
7-07918 10µg Ask for price

Influenza B Virus Florida 07/04
7-07919 50µg Ask for price

Influenza B Virus Florida 07/04
7-07920 1mg Ask for price

Influenza-B Virus Florida 07/04
rAP-5412 Inquiry Ask for price

Influenza A H1N1 (A/California/07/2009) HA protein, His Tag
E40VAG044 20ug
EUR 495

Molecular docking and dynamics simulations research of OmpATb identifies 4 potential novel pure product-derived anti-Mycobacterium tuberculosis compounds

The outer membrane protein A (OmpATb) of Mycobacterium tuberculosis is a virulence issue that neutralizes the host pH to impede the uptake of hydrophilic antitubercular medicine.
Figuring out pure compounds with the potential to inhibit OmpATb might permit circumvention of the porin-like actions of OmpATb. 4 potential leads comprising ZINC000003958185, ZINC000000157405, ZINC000000001392 and ZINC000034268676 had been obtained by digital screening of 6394 various pure merchandise.
Characterization of the binding interactions of the potential leads with OmpATb revealed 9 essential residues comprising ARG86, LEU110, LEU113, LEU114, ALA115, PHE142, SER145, VAL146, and PHE151. Molecular dynamics simulations additionally revealed very secure protein-lead complexes.
Most residues contributed decrease binding energies to the general molecular mechanics Poisson-Boltzmann floor space (MM-PBSA) binding free energies of the interactions between the molecules and OmpATb protein.
Induced Match Docking (IFD) of the compounds regenerated poses of the molecular docking utilizing AutoDock Vina. These molecules might be beginning templates for designing inhibitors to bypass the pore mediating actions of OmpATb.
Based mostly on structural similarity, ZINC000034268676 was urged as a possible scaffold for designing efflux pump inhibitors of the gate mediating actions of OmpATb and should improve the uptake of hydrophilic medicine to scale back the length time of tuberculosis therapy.
Moreover, structurally comparable compounds obtainable within the DrugBank database with a similarity threshold of 0.7 have been reported to exhibit antitubercular and anti-mycobacterial actions.
These biomolecules may be additional characterised experimentally to corroborate their antitubercular exercise. Additionally, the skeletons of the molecules may be adopted as sub-structures for the design of future anti-mycobacterial medicine.
Key phrases: Antitubercular compounds; Induced-fit docking; MM-PBSA; Molecular docking; Molecular dynamics; Mycobacterium tuberculosis OmpATb; Pure merchandise; Digital screening.

Probing the Molecular-Stage Interactions in an Energetic Pharmaceutical Ingredient (API) – Polymer Dispersion and the Ensuing Affect on Drug Product Formulation.

An investigation of underlying mechanisms of API-polymer interplay patterns has the potential to offer helpful insights for choosing applicable formulations with superior bodily stability and processability.
On this examine, copovidone was used as a polymeric provider for a number of mannequin compounds together with clotrimazole, nifedipine, and posaconazole.
The various chemical constructions conferred the power for the mannequin compounds to type distinct interactions with copovidone. Rheology and nuclear magnetic resonance (NMR) had been mixed to research the molecular sample and relative power of energetic pharmaceutical ingredient (API)-polymer interactions.
As well as, the affect of the interactions on formulation processability by way of sizzling soften extrusion (HME) and bodily stability had been evaluated.The rheological response of an API-polymer system was discovered to be extremely delicate to API-polymer interplay, relying each on API chemistry and API-polymer miscibility.
Within the techniques studied, dispersed API induced a stronger plasticizer impact on the polymer matrix in comparison with crystalline/aggregated API.
Correspondingly, the processing torque by way of HME confirmed a proportional relationship with the utmost advanced viscosity of the API-polymer system. To be able to quantitatively consider the relative power of the API-polymer interplay, homogeneously dispersed API-polymer amorphous samples had been ready by HME at an elevated temperature. DSC, XRD, and rheology had been employed to verify the amorphous integrity and homogeneity of the resultant extrudates.
Subsequently, the homogeneously dispersed API-polymer amorphous dispersions had been interrogated by rheology and NMR to offer a qualitative and quantitative evaluation of the character of the API-polymer interplay, each macroscopically and microscopically.
Rheological grasp curves of frequency sweeps of the extrudates exhibited a powerful dependence on the API chemistry and revealed a rank ordering of the relative power of API-copovidone interactions, within the order of posaconazole > nifedipine > clotrimazole.
NMR knowledge offered the means to exactly map the API-polymer interplay sample and determine the particular websites of interplay from a molecular perspective. Lastly, the affect of API-polymer interactions on the bodily stability of the resultant extrudates was studied.
Qualitative and quantitative analysis of the relative power of the API-polymer interplay was efficiently achieved by using mixed rheology and NMR. Graphical Summary.

anti- Galectin-1 antibody
FNab03314 100µg
EUR 606.3
Description: Antibody raised against Galectin-1

anti- Galectin-1 antibody
FNab03315 100µg
EUR 658.5
Description: Antibody raised against Galectin-1

Anti- Galectin-1 Antibody
GWB-6F6392 0.1 mg Ask for price

Human Galectin-1 (Gal-1) Antibody
30005-05111 150 ug
EUR 215

Human Galectin-1 (LGALS1)
1-CSB-EP012882HU
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100ug
  • 10ug
  • 1MG
  • 200ug
  • 500ug
  • 50ug
Description: Recombinant Human Galectin-1(LGALS1) expressed in E.coli

Human Galectin-1 (LGALS1)
1-CSB-EP012882HUb1
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100ug
  • 10ug
  • 1MG
  • 200ug
  • 500ug
  • 50ug
Description: Recombinant Human Galectin-1(LGALS1) expressed in E.coli

Human Galectin-3(Galectin-3)ELISA Kit
YLA0216HU-48T 48T Ask for price

Human Galectin-3(Galectin-3)ELISA Kit
YLA0216HU-96T 96T Ask for price

human anti-human galectin-3 mAb(2D)
E4A09H10-2D 50ug
EUR 275
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

human anti-human galectin-3 mAb(5F)
E4A09H10-5F 50ug
EUR 275
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

human anti-human galectin-3 mAb(A5)
E4A09H10-A5 50ug
EUR 275
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

human anti-human galectin-3 mAb(G2)
E4A09H10-G2 50ug
EUR 275
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

human anti-human galectin-3 mAb(H3)
E4A09H10-H3 50ug
EUR 275
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

human anti-human galectin-3 mAb(T1)
E4A09H10-T1 50ug
EUR 275
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

human anti-human galectin-3 mAb(N13)
E4A09H10-N13 50ug
EUR 275
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

Anti Human Galectin-3 Polyclonal Antibody
KH040 each
EUR 778.8
Description: The Anti Human Galectin-3 Polyclonal Antibody is available in Europe and for worldwide shipping via Gentaur.

Recombinant Human Galectin-1
7-00427 10µg Ask for price

Recombinant Human Galectin-1
7-00428 50µg Ask for price

Recombinant Human Galectin-1
7-00429 1mg Ask for price

Recombinant Human Galectin-1
AP60482 100ug
EUR 449

Recombinant Human Galectin-1
HEOPP-0710 10ug Ask for price

RECOMBINANT HUMAN GALECTIN-1
GWB-BEA2B0 0.05 mg Ask for price

Recombinant Human Galectin-1
cyt-544-10g 10µg
EUR 60

Recombinant Human Galectin-1
cyt-544-1mg 1mg
EUR 1350

Recombinant Human Galectin-1
cyt-544-50g 50µg
EUR 145

Human Galectin 1 Protein
20-abx066725
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Human Galectin-1 Antibody Pair Set
ABPR-ZB244 5 plates, 15 plates Ask for price
Description: Quantitative determination of Human Galectin-1

Galectin-1, human recombinant
4648-10 each
EUR 170.4

Galectin-1, human recombinant
4648-1000 each
EUR 1977.6

Galectin-1, human recombinant
4648-50 each
EUR 314.4

Galectin-1 Human Recombinant
rAP-2252 Inquiry Ask for price

Human Galectin-1 ELISA Kit
EK5323 96 tests
EUR 599

Human Galectin-1 ELISA Kit
IHULGALS1KT each
EUR 702
Description: Human Galectin-1 ELISA Kit

Mouse Monoclonal anti-human Galectin-1
hAP-1228 50ug
EUR 400

Sheep Polyclonal anti-Human Galectin-1
hAP-5905 50ug
EUR 400

Anti-Mouse Galectin-1 Antibody
103-M223 100 µg
EUR 399
Description: The galectins constitute a large family of carbohydrate-binding proteins that function in many systems both intracellularly and following secretion. Galectins contain either one or two carbohydrate recognition domains (CRR) which mediate recognition of N-acetyl-lactosamine-containing glycoproteins. Some galectins exist in multiple isoforms due to alternative splicing. Individual galectins differ in their tissue distribution and in their carbohydrate-binding specificities.

Human Galectin-1 (LEG1) Protein
abx690252-100g 100 µg
EUR 837.5

Human Galectin-1 (LEG1) Protein
abx690252-20g 20 µg
EUR 350

Human Galectin 1 (GAL1) ELISA
KT-15605 96 tests
EUR 952

Human Galectin-1 (LGALS1) Protein
abx670211-50ug 50 ug
EUR 661.2

Human Galectin 1 ELISA kit
E01A4669 96T
EUR 700
Description: ELISA

Human Galectin 1 ELISA kit
E01G0038-192T 192 tests
EUR 1524
Description: A sandwich ELISA for quantitative measurement of Human Galectin 1 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Human Galectin 1 ELISA kit
E01G0038-48 1 plate of 48 wells
EUR 624
Description: A sandwich ELISA for quantitative measurement of Human Galectin 1 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Human Galectin 1 ELISA kit
E01G0038-96 1 plate of 96 wells
EUR 822
Description: A sandwich ELISA for quantitative measurement of Human Galectin 1 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Human Galectin 1 ELISA Kit
IHUGAL1KT each
EUR 667
Description: Human Galectin 1 ELISA Kit

Galectin-10， Human
E34M155H 5 μg
EUR 155

Galectin-12， Human
E34M156H 5 μg
EUR 155

Galectin-13， Human
E34M157H 5 μg
EUR 155

Galectin-14， Human
E34M158H 5 μg
EUR 155

Galectin-16， Human
E34M159H 5 μg
EUR 155

Galectin-2， Human
E34M149H 5 μg
EUR 155

Galectin-3， Human
E34M150H 5 μg
EUR 155

Galectin-4， Human
E34M151H 5 μg
EUR 155

Galectin-7， Human
E34M152H 5 μg
EUR 155

Galectin-8， Human
E34M153H 5 μg
EUR 155

Galectin-9， Human
E34M154H 5 μg
EUR 155

Galectin-3 Human
GWB-1FDCC0 0.05 mg Ask for price

anti-human Galectin-3 antibody
10-2887 250 ug
EUR 410
Description: Purified anti-human Galectin-3 antibody

Anti-Human Galectin-3 Antibody
102-P228 100 µg
EUR 245.7
Description: The galectins constitute a large family of carbohydrate-binding proteins that function in many systems both intracellularly and following secretion. Galectins contain either one or two carbohydrate recognition domains (CRR) which mediate recognition of N-acetyl-lactosamine-containing glycoproteins. Some galectins exist in multiple isoforms due to alternative splicing. Individual galectins differ in their tissue distribution and in their carbohydrate-binding specificities.

Anti-Human Galectin-3 Antibody
101-M424 100 µg
EUR 399
Description: The galectins constitute a large family of carbohydrate-binding proteins that function in many systems both intracellularly and following secretion. Galectins contain either one or two carbohydrate recognition domains (CRR) which mediate recognition of N-acetyl-lactosamine-containing glycoproteins. Some galectins exist in multiple isoforms due to alternative splicing. Individual galectins differ in their tissue distribution and in their carbohydrate-binding specificities.

Anti-Human Galectin-4 Antibody
101-M425 100 µg
EUR 399
Description: Galectin-4 is a member of the subfamily of galectins composed of two carbohydrate recognition domains having similar peptide chains. The galectins are a family of beta-galactoside-binding proteins having a role in modulating cell-cell and cell-matrix interactions, which inhibits chronic inflammations, GVHD, and allergic responses. LGALS4 expression is limited to small intestine, colon, and rectum, and it is underexpressed in colorectal cancer. LGALS4 binds as an endogenous ligand to glycosphingolipids having 3-O-sulfated Gal residues and bind as well to cholesterol-3-sulfate. LGALS4 takes part in cell adhesion. LGALS4 plays a role in crosslinking the lateral cell membranes of the surface-lining epithelial cells, thus supporting epithelial integrity against mechanical stress exerted by the bowel lume.

Anti-Human Galectin-8 Antibody
101-M427 100 µg
EUR 399
Description: LGALS8 is a prostate-specific antigen that is solely overexpressed in malignant tumors and thus is a supplementary specific identifier of malignancies. LGALS8 is part of the galectin gene family which facilitates both cell-cell and cell matrix interactions in a method parallel to the selectin subgroup of C-type lectins.

Anti-Human Galectin-3 Antibody
101-M747 100 µg
EUR 399
Description: The galectins constitute a large family of carbohydrate-binding proteins that function in many systems both intracellularly and following secretion. Galectins contain either one or two carbohydrate recognition domains (CRR) which mediate recognition of N-acetyl-lactosamine-containing glycoproteins. Some galectins exist in multiple isoforms due to alternative splicing. Individual galectins differ in their tissue distribution and in their carbohydrate-binding specificities.

Anti-Human Galectin-7 Antibody
101-M748 100 µg
EUR 399
Description: Galectin-7 is a protein that in humans is encoded by the LGALS7 gene. The galectins are a family of beta-galactoside-binding proteins implicated in modulating cell–cell and cell–matrix interactions. Differential and in situ hybridizations indicate that this lectin is specifically expressed in keratinocytes. It is expressed at all stages of epidermal differentiation (i.e., in basal and supra-basal layers). It is moderately repressed by retinoic acid. The protein was found mainly in stratified squamous epithelium. The antigen localized to basal keratinocytes, although it was also found, albeit at lower levels, in the supra-basal layers where it concentrated to areas of cell-to-cell contact. The cellular localization and it’s striking down-regulation in cultured keratinocytes imply a role in cell–cell and/or cell–matrix interactions necessary for normal growth control.

Anti-human Galectin-3 antibody
STJ15100163 250 µg
EUR 403.2
Description: This monoclonal antibody is for studies of antigen expression in cells and tissue sections using immunocytochemistry and immunoprecipitation

Recombinant Human Galectin-1 (LGALS1)
CSB-EP012882HU 1598 mg Ask for price

Recombinant Human Galectin-1 (LGALS1)
CSB-EP012882HUb1 1599 mg Ask for price

Recombinant Human Galectin-1(LGALS1)
AP70493 1mg
EUR 1978

Recombinant Human Galectin-1 (LGALS1)
Z101845 15 µg
EUR 105
Description: Galectin-1 is a member of the galectin family, and binds B-galactosidase moieties on glycoproteins or glycolipids. Galectins are primarily involved in modulation of cell-cell and cell-matrix interactions. Galectin-1 acts as a negative regulator of immunity, promoting immune suppression and lessening the inflammatory response. Galectin-1 binds CD45, CD3 and CD4, resulting in the inhibition of CD45 phosphatase dependant dephosphorylation of lyn kinase, as well as a number of other immune related receptors. Due to its function as a negative regulator of the immune response, and role inducing apoptosis in activated Th1 and Th17 cells, it is commonly found upregulated around malignant tumours. It has also been implicated as having a role in the development of immune tolerance during pregnancy, and is highly expressed at the maternal-fetal interface. As a dimer it down-regulates neutrophils by inducing exposure of phosphatidylserine, thereby marking the cell for apoptosis. It shares approximately 88% and 90% sequence similarity with mouse and rat galectin-1, respectively. Recombinant Human Galectin-1 is a 14.9kDa protein.

Recombinant Human Galectin-1 (LGALS1)
Z101847 100 µg
EUR 270
Description: Galectin-1 is a member of the galectin family, and binds B-galactosidase moieties on glycoproteins or glycolipids. Galectins are primarily involved in modulation of cell-cell and cell-matrix interactions. Galectin-1 acts as a negative regulator of immunity, promoting immune suppression and lessening the inflammatory response. Galectin-1 binds CD45, CD3 and CD4, resulting in the inhibition of CD45 phosphatase dependant dephosphorylation of lyn kinase, as well as a number of other immune related receptors. Due to its function as a negative regulator of the immune response, and role inducing apoptosis in activated Th1 and Th17 cells, it is commonly found upregulated around malignant tumours. It has also been implicated as having a role in the development of immune tolerance during pregnancy, and is highly expressed at the maternal-fetal interface. As a dimer it down-regulates neutrophils by inducing exposure of phosphatidylserine, thereby marking the cell for apoptosis. It shares approximately 88% and 90% sequence similarity with mouse and rat galectin-1, respectively. Recombinant Human Galectin-1 is a 14.9kDa protein.

Recombinant Human Galectin-1 (LGALS1)
Z101849 1.0 mg
EUR 1135
Description: Galectin-1 is a member of the galectin family, and binds B-galactosidase moieties on glycoproteins or glycolipids. Galectins are primarily involved in modulation of cell-cell and cell-matrix interactions. Galectin-1 acts as a negative regulator of immunity, promoting immune suppression and lessening the inflammatory response. Galectin-1 binds CD45, CD3 and CD4, resulting in the inhibition of CD45 phosphatase dependant dephosphorylation of lyn kinase, as well as a number of other immune related receptors. Due to its function as a negative regulator of the immune response, and role inducing apoptosis in activated Th1 and Th17 cells, it is commonly found upregulated around malignant tumours. It has also been implicated as having a role in the development of immune tolerance during pregnancy, and is highly expressed at the maternal-fetal interface. As a dimer it down-regulates neutrophils by inducing exposure of phosphatidylserine, thereby marking the cell for apoptosis. It shares approximately 88% and 90% sequence similarity with mouse and rat galectin-1, respectively. Recombinant Human Galectin-1 is a 14.9kDa protein.

Human Galectin-1 ELISA ELISA Kit
E16HE0311 96T
EUR 1000

Human Galectin-1 Recombinant Protein
100-175 50 µg
EUR 196.35
Description: Lectins, of either plant or animal origin, are carbohydrate binding proteins that interact with glycoprotein and glycolipids on the surface of animal cells. The Galectins are lectins that recognize and interact with β-galactoside moieties. Galectin-1 is an animal lectin that has been shown to interact with CD3, CD4, and CD45. It induces apoptosis of activated T-cells and T-leukemia cell lines and inhibits the protein phosphatase activity of CD45. Recombinant human Galectin-1 is a 14.5 kDa protein containing 134 amino acid residues.

Human Galectin-1 Recombinant Protein
100-175S 10 µg
EUR 92.4
Description: Lectins, of either plant or animal origin, are carbohydrate binding proteins that interact with glycoprotein and glycolipids on the surface of animal cells. The Galectins are lectins that recognize and interact with β-galactoside moieties. Galectin-1 is an animal lectin that has been shown to interact with CD3, CD4, and CD45. It induces apoptosis of activated T-cells and T-leukemia cell lines and inhibits the protein phosphatase activity of CD45. Recombinant human Galectin-1 is a 14.5 kDa protein containing 134 amino acid residues.

Human Galectin-1 Recombinant Protein
400-015 50 µg
EUR 126
Description: Lectins, of either plant or animal origin, are carbohydrate binding proteins that interact with glycoprotein and glycolipids on the surface of animal cells. The Galectins are lectins that recognize and interact with beta-galactoside moieties. Galectin-1 is an animal lectin that has been shown to interact with CD3, CD4, and CD45. It induces apoptosis of activated T-cells and T-leukemia cell lines and inhibits the protein phosphatase activity of CD45. Recombinant human Galectin-1 is a 14.5 kDa protein containing 134 amino acid residues.

Recombinant Human Galectin-1 Protein
E40KMP1041 20ug
EUR 495

Recombinant Human Galectin-1 Protein
PROTP09382-1 50ug
EUR 380.4
Description: Lectins, of either plant or animal origin, are carbohydrate binding proteins that interact with glycoprotein and glycolipids on the surface of animal cells. The Galectins are lectins that recognize and interact with β-galactoside moieties. Galectin-1 is an animal lectin that has been shown to interact with CD3, CD4, and CD45. It induces apoptosis of activated T-cells and T-leukemia cell lines and inhibits the protein phosphatase activity of CD45. Recombinant human Galectin-1 is a 14.5 kDa protein containing 134 amino acid residues.

Human Galectin 10 Antibody
32652-05111 150 ug
EUR 215

Human Galectin 8 Antibody
33159-05111 150 ug
EUR 215

Human Galectin 2 Antibody
33165-05111 150 ug
EUR 215

Human Galectin 13 Antibody
33175-05111 150 ug
EUR 215

Human Galectin 1 (LGALS1) Protein
abx066725-100g 100 µg
EUR 512.5

Human Galectin 1 (LGALS1) Protein
abx066725-10g 10 µg
EUR 212.5

Human Galectin 1 (LGALS1) Protein
abx066725-50g 50 µg
EUR 362.5

Human Galectin 1 (LGALS1) Protein
abx670211-100g 100 µg
EUR 450

Human Galectin-1(LGALS1) ELISA kit
E01A4871 96T
EUR 700
Description: ELISA

Human Galectin-1(LGALS1) ELISA kit
E01G0448-192T 192 tests
EUR 1524
Description: A competitive ELISA for quantitative measurement of Human Galectin-1(LGALS1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Human Galectin-1(LGALS1) ELISA kit
E01G0448-48 1 plate of 48 wells
EUR 624
Description: A competitive ELISA for quantitative measurement of Human Galectin-1(LGALS1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Human Galectin-1(LGALS1) ELISA kit
E01G0448-96 1 plate of 96 wells
EUR 822
Description: A competitive ELISA for quantitative measurement of Human Galectin-1(LGALS1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Omar

Leave A Comment

April 2024
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930